CytoMed Therapeutics Limited (GDTC) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

CytoMed Therapeutics Limited (GDTC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $12.1M, listed on NASDAQ, employing roughly 42 people, carrying a beta of 0.02 to the broader market. CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. Led by Chee Kong Choo, public since 2023-04-14.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for GDTC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →